CpG-Islands as Markers for Liquid Biopsies of Cancer Patients
The analysis of tumours using biomarkers in blood is transforming cancer diagnosis and therapy. Cancers are characterised by evolving genetic alterations, making it difficult to develop reliable and broadly applicable DNA-based biomarkers for liquid biopsy. In contrast to the variability in gene mut...
Main Authors: | Maximilian Sprang, Claudia Paret, Joerg Faber |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-08-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/9/8/1820 |
Similar Items
-
CpG Methylation Altered the Stability and Structure of the i-Motifs Located in the CpG Islands
by: Daiki Oshikawa, et al.
Published: (2022-06-01) -
Evolution of CpG-islands by means of tandem duplications
by: V. N. Babenko, et al.
Published: (2017-02-01) -
Synthetic CpG islands reveal DNA sequence determinants of chromatin structure
by: Elisabeth Wachter, et al.
Published: (2014-09-01) -
KDM2B links the Polycomb Repressive Complex 1 (PRC1) to recognition of CpG islands
by: Anca M Farcas, et al.
Published: (2012-12-01) -
Loss of CpG island immunity to DNA methylation induced by mutation
by: Bernhard Horsthemke, et al.
Published: (2023-05-01)